Texas childrens hospital

Houston, Texas 80218

116 studies enrolling now · 688 studies all time

What they study most

16P11.2 Deletion Syndrome, AADC Deficiency, AAOCA, ADA SCID, ADA-SCID, ADH Inappropriate, ALL, AML, APDS, Abdominal Pain, Abscess, Absence of Uterus

Studies at this site

• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — Recruiting now
• A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer — Recruiting now
• Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients — Recruiting now
• Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors — Recruiting now
• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome — Recruiting now
• C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) — Recruiting now
• REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome — Recruiting now
• Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy — Recruiting now
• Danon Disease Natural History Study — Recruiting now
• First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. — Recruiting now
• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis — Recruiting now
• PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors — Recruiting now
• A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy — Recruiting now
• NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma — Recruiting now
• Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas — Recruiting now
• Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas — Recruiting now
• AERA Pediatrics Registry — Recruiting now
• Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset — Recruiting now
• Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS) — Recruiting now
• Distal Radius Interventions for Fracture Treatment — Recruiting now
• Rett Syndrome Registry — Recruiting now
• Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion — Recruiting now
• A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects — Recruiting now
• EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma — Recruiting now
• A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee — Recruiting now
• Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors — Recruiting now
• Childhood Cancer Survivor Study — Recruiting now
• Study of Olutasidenib and Temozolomide in HGG — Recruiting now
• A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study) — Recruiting now
• TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. — Recruiting now
• Targeted Pediatric High-Grade Glioma Therapy — Recruiting now
• CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) — Recruiting now
• Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations — Recruiting now
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — Recruiting now
• Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders — Recruiting now
• VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors — Recruiting now
• A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition — Recruiting now
• Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant — Recruiting now
• Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) — Recruiting now
• Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) — Recruiting now
• Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells — Recruiting now
• ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas — Recruiting now
• QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry — Recruiting now
• HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN) — Recruiting now
• Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases — Recruiting now
• PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) — Recruiting now
• Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story — Recruiting now
• Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI) — Recruiting now
• ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma — Recruiting now